| Dr Beth Melanie May, DO | |
|
2510 Chickasaw Blvd, Ardmore, OK 73401-1341 | |
| (580) 226-8181 | |
| Not Available |
| Full Name | Dr Beth Melanie May |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 28 Years |
| Location | 2510 Chickasaw Blvd, Ardmore, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497743611 | NPI | - | NPPES |
| 100075390B | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 3447 (Oklahoma) | Secondary |
| 207P00000X | Emergency Medicine | 3447 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Elara Caring Xxi | Purcell, OK | Home health agency |
| Chickasaw Nation Medical Center | Ada, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chickasaw Nation Division Of Health | 8426957523 | 209 |
News Archive
Past randomized clinical trials have shown that non-steroidal anti-inflammatory drugs (NSAIDs), including naproxen, can reduce the risk of colon cancer and precancerous polyps in humans. Now, researchers at Fox Chase Cancer Center have found that an investigational form of naproxen, called nitric oxide-donating naproxen (NO-naproxen), can block one of the earliest molecular changes that lead to colorectal cancer development while also reducing gastrointestinal toxicity, a relatively common side effect associated with NSAIDs.
A new study presents more evidence of a possible link between low vitamin D levels and a higher risk of Type 2 diabetes and heart disease. The results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston.
Each day in the United States, 482 people are diagnosed with a brain tumor. For these 482 people, not many treatments exist. With the current treatments available, only 5% of those diagnosed with a Glioblastoma Multiform will survive more than 5 years. Only two new treatments have been approved by the FDA in the past two decades.
Onyx Pharmaceuticals, Inc. today announced positive top-line results from the Phase 2b 003-A1 study of single-agent carfilzomib, a selective, next generation proteasome inhibitor, in patients with relapsed and refractory multiple myeloma.
FamilyCord, a subsidiary of California Cryobank, announced the recent asset acquisition of Vista Cord, a regional cord blood bank primarily servicing the southern US states. In conjunction with the FDA and cryogenic transport experts, FamilyCord has successfully relocated all cord blood units to their state-of-the-art facility in Los Angeles.
› Verified 2 days ago
| Entity Name | Chickasaw Nation Division Of Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255364923 PECOS PAC ID: 8426957523 Enrollment ID: O20040108000364 |
News Archive
Past randomized clinical trials have shown that non-steroidal anti-inflammatory drugs (NSAIDs), including naproxen, can reduce the risk of colon cancer and precancerous polyps in humans. Now, researchers at Fox Chase Cancer Center have found that an investigational form of naproxen, called nitric oxide-donating naproxen (NO-naproxen), can block one of the earliest molecular changes that lead to colorectal cancer development while also reducing gastrointestinal toxicity, a relatively common side effect associated with NSAIDs.
A new study presents more evidence of a possible link between low vitamin D levels and a higher risk of Type 2 diabetes and heart disease. The results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston.
Each day in the United States, 482 people are diagnosed with a brain tumor. For these 482 people, not many treatments exist. With the current treatments available, only 5% of those diagnosed with a Glioblastoma Multiform will survive more than 5 years. Only two new treatments have been approved by the FDA in the past two decades.
Onyx Pharmaceuticals, Inc. today announced positive top-line results from the Phase 2b 003-A1 study of single-agent carfilzomib, a selective, next generation proteasome inhibitor, in patients with relapsed and refractory multiple myeloma.
FamilyCord, a subsidiary of California Cryobank, announced the recent asset acquisition of Vista Cord, a regional cord blood bank primarily servicing the southern US states. In conjunction with the FDA and cryogenic transport experts, FamilyCord has successfully relocated all cord blood units to their state-of-the-art facility in Los Angeles.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Beth Melanie May, DO 1921 Stonecipher Dr, Ada, OK 74820-3439 Ph: (580) 310-5687 | Dr Beth Melanie May, DO 2510 Chickasaw Blvd, Ardmore, OK 73401-1341 Ph: (580) 226-8181 |
News Archive
Past randomized clinical trials have shown that non-steroidal anti-inflammatory drugs (NSAIDs), including naproxen, can reduce the risk of colon cancer and precancerous polyps in humans. Now, researchers at Fox Chase Cancer Center have found that an investigational form of naproxen, called nitric oxide-donating naproxen (NO-naproxen), can block one of the earliest molecular changes that lead to colorectal cancer development while also reducing gastrointestinal toxicity, a relatively common side effect associated with NSAIDs.
A new study presents more evidence of a possible link between low vitamin D levels and a higher risk of Type 2 diabetes and heart disease. The results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston.
Each day in the United States, 482 people are diagnosed with a brain tumor. For these 482 people, not many treatments exist. With the current treatments available, only 5% of those diagnosed with a Glioblastoma Multiform will survive more than 5 years. Only two new treatments have been approved by the FDA in the past two decades.
Onyx Pharmaceuticals, Inc. today announced positive top-line results from the Phase 2b 003-A1 study of single-agent carfilzomib, a selective, next generation proteasome inhibitor, in patients with relapsed and refractory multiple myeloma.
FamilyCord, a subsidiary of California Cryobank, announced the recent asset acquisition of Vista Cord, a regional cord blood bank primarily servicing the southern US states. In conjunction with the FDA and cryogenic transport experts, FamilyCord has successfully relocated all cord blood units to their state-of-the-art facility in Los Angeles.
› Verified 2 days ago
Mark Damon Ii, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1011 14th Ave Nw, Ardmore, OK 73401 Phone: 580-220-6658 Fax: 580-220-6673 | |
Ernest Byron Foster Ii, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1011 14th Ave Nw, Ardmore, OK 73401 Phone: 580-220-6658 Fax: 580-220-6673 | |
Dr. Daniel Ryan Wheeler, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1011 14th Ave Nw, Ardmore, OK 73401 Phone: 580-220-6588 | |
Lindsay Anne Wilson, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1011 14th Ave Nw, Ardmore, OK 73401 Phone: 580-220-6132 Fax: 580-220-6772 | |
Daniel Francis Mckinley, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 14th Ave Nw, Ardmore, OK 73401 Phone: 580-220-6658 Fax: 580-220-6673 | |
Dr. Jason Andrew Carter, MD, MHSA, FACEP Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1405 4th Ave Nw Ste 96, Ardmore, OK 73401 Phone: 417-612-3985 | |
Dr. Carl Allen Thompson, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 14th Ave Nw, Ardmore, OK 73401 Phone: 580-220-6658 Fax: 580-220-6673 |